APPENDIX 1
COMPLIANCE GLOSSARY | + open

APPENDIX 2
US FCPA RESOURCE GUIDE, DOJ & SEC | + open

APPENDIX 3
GUIDE TO COMPETITION IN APAC, BAKER & MCKENZIE (2010) | + open

APPENDIX 4
RECENT FCPA DEVELOPMENTS, ARNOLD & PORTER (2012) | + open

APPENDIX 5
JPMA PROMOTION CODE FOR PRESCRIPTION DRUGS (REV. 2012) | + open

APPENDIX 6
SAPI CODE OF MARKETING PRACTICES (REV. 2012) | + open

APPENDIX 7
PReMA THAILAND CODE OF SALE & MARKETING PRACTICES (8TH ED., 2008) | + open

APPENDIX 8
IFPMA CODE OF PRACTICE (2012) | + open

APPENDIX 9
INSEAD HEALTHCARE COMPLIANCE IMPLEMENTATION LEADERSHIP PROGRAMS | + open

APPENDIX 10
ANTI-CORRUPTION LAWS IN ASIA PACIFIC, NORTON ROSE (2012) | + open

APPENDIX 11
CORRUPTION PERCEPTIONS INDEX 2012, TRANSPARENCY INTERNATIONAL | + open

APPENDIX 12
50 JAW-DROPPING PHARMACEUTICAL, BIOTECH, AND LIFE SCIENCE STATISTICS,
THE MOTLEY FOOL (2013) | + open
 
APPENDIX 13
THE ASIA PACIFIC TOP 10 FCPA CASES OF 2011, CORPORATE COMPLIANCE INSIGHTS | + open

APPENDIX 14
LIFE SCIENCE COMPLIANCE ISSUE (4/2012) | + open

APPENDIX 15
ASIA-PACIFIC HCCP FACULTY BIOGRAPHIES | + open

APPENDIX 16
COST OF COMPLIANCE SURVEY 2013, THOMSON REUTERS | + open

APPENDIX 17
ASIA-PACIFIC HEALTHCARE COMPLIANCE CERTIFICATION PROGRAM CURRICULUM | + open